We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Routine Blood Glucose Measurements Can Accurately Estimate HbA1c

By LabMedica International staff writers
Posted on 06 May 2014
Glycated hemoglobin or HbA1c is the standard measurement for assessing glycemic control over time in people with diabetes and blood levels of HbA1c are typically measured every few months in a laboratory.

The relationship between HbA1c and average glucose levels could determine whether HbA1c could be expressed and reported as average glucose in the same units as used in self-monitoring which could increase individuals' motivation to improve diabetes control. More...


Scientists at the University of Virginia (Charlottesville, VA, USA) working with those at Sanofi-Aventis Deutschland GmbH (Frankfurt, Germany) developed a data-based model that accurately estimates HbA1c using self-monitored blood glucose (SMBG) readings. The computer algorithm they developed was based on a training data set drawn from 379 subjects and then evaluated for accuracy on an independent test data set. The average HbA1c level was 7.6% (± 1.1%), with minimum and maximum values of 5.2% and 12.2%, respectively.

A conceptually new, clinically viable procedure was developed for real-time tracking of average glycaemia from self-monitoring data. The average glucose tracing can then be converted into running estimates of HbA1c, which can be presented to the patient daily. The computational demands of the procedure are low and therefore readily implementable into devices with limited processing power, such as home SMBG meter.

The procedure, tracking average glycaemia and HbA1c in real time, could provide valuable assistance to the daily optimization of diabetes control. The procedure is not intended as a substitute for laboratory assessments of HbA1c and it should be viewed as a surrogate measure that allows convenient tracing of average glucose, readily implementable in a point-of-care SMBG device.

Satish Garg, MD, a professor of medicine and pediatrics at the University of Colorado (Denver, CO, USA) said, “Patients are used to a HbA1c result from their doctor visits, and this study highlights simple estimated HbA1c values from SMBG data. This may become an important tool for improved patient self-management.” The study was published on April 23, 2014, in the journal Diabetes Technology & Therapeutics.

Related Links:

University of Virginia 
Sanofi-Aventis Deutschland GmbH 
University of Colorado



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic CLIA Analyzer
Shine i6000
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.